已收盤 05-08 16:00:00 美东时间
-0.920
-0.82%
默沙东 默沙东持续通过研发与收购扩展研发管线。今年3月,该公司斥资约67亿美元收购了Terns Pharmaceuticals,获得治疗慢性髓系白血病...
05-09 07:31
尽管原告律师面临重重障碍,但一旦胜诉,默沙东或将向数百名年轻女性支付巨额赔偿。这些女性声称,接种这款畅销疫苗后,自身出现不孕问题,或是患上严重自身免疫性疾病、心脏功能受损。
05-08 20:20
5月8日消息,国家药品监督管理局旗下中国食品药品检定研究院披露的生物制品批签发产品公示情况显示,2026年4月27日至2026年5月3日,中国食品药品检定研究院...
05-08 20:16
(来源:中国食品药品网) 历经4年深度调整,全球创新药行业正迎来资金回流的关键信号:二级市场震荡上行、跨国药企(MNC)掀起收购潮、头部私募基金募资额创历史新高...
05-08 09:42
In this publication, Merck scientists detail the biocatalytic assembly of enlicitide using a suite of enzymes that catalyze selective peptide fragment formation, coupling, and macrocyclization. Together with efficient
05-08 02:09
Pyxis Oncology appoints Nelson Azoulay as Chief Business Officer. With over 15 years of experience in corporate strategy and biopharma transactions, Azoulay will lead corporate development and advance MICVO, the company's lead ADC targeting EDB+FN in solid tumors. MICVO is in Phase 1/2 trials for recurrent/metastatic head and neck cancer and has received FDA Fast Track Designation. Azoulay's expertise in ADCs and strategic transactions is expecte...
05-07 20:05
1.5月6日,瑞博生物宣布与勃林格殷格翰(BI)在代谢功能障碍相关脂肪性肝炎(MASH)领域的siRNA合作达成第三个关键里程碑 此次进展标志着双方合作研发进...
05-07 17:24
礼来Mounjaro已超越默沙东的癌症治疗药物Keytruda,成为全球最畅销的药物。
05-07 07:57
经济观察网 默沙东近期披露收购进展及最新业绩指引,已完成对Cidara Therapeutics收购,同时上调2026年营收及每股收益预期。 业务进展情况 近期...
05-06 01:06
华盛资讯5月5日讯,默沙东公布2026财年Q1业绩,公司Q1营收162.86亿美元,同比增长4.9%,归母净利润亏损42.40亿美元,由盈转亏。
05-05 06:07
公司名稱
|
默沙东
|
行業分類
|
制药
|
業務描述
|
默沙东公司是世界级跨国医药企业领导者,着手解决社会对医疗健康上的需要。默沙东提供创新的药物、疫苗、生物制剂及健康消费品以及动物健康产品,以改善及提升健康质素。默沙东现时已于全球140个不同地方为消费者提供医疗健康解决方案。同时藉由深入各地区角落的医疗计划,提供药品给需要的人们,以解决偏远地区医疗不足的情况。默沙东在美国及加拿大内称为默克药厂(Merck & Co., Inc.),在其他不同地区则以默沙东药厂(Merck Sharp & Dohme,MSD)为名。
|
默沙东 默沙东持续通过研发与收购扩展研发管线。今年3月,该公司斥资约67亿美元收购了Terns Pharmaceuticals,获得治疗慢性髓系白血病...
05-09 07:31
尽管原告律师面临重重障碍,但一旦胜诉,默沙东或将向数百名年轻女性支付巨额赔偿。这些女性声称,接种这款畅销疫苗后,自身出现不孕问题,或是患上严重自身免疫性疾病、心脏功能受损。
05-08 20:20
5月8日消息,国家药品监督管理局旗下中国食品药品检定研究院披露的生物制品批签发产品公示情况显示,2026年4月27日至2026年5月3日,中国食品药品检定研究院...
05-08 20:16
(来源:中国食品药品网) 历经4年深度调整,全球创新药行业正迎来资金回流的关键信号:二级市场震荡上行、跨国药企(MNC)掀起收购潮、头部私募基金募资额创历史新高...
05-08 09:42
In this publication, Merck scientists detail the biocatalytic assembly of enlicitide using a suite of enzymes that catalyze selective peptide fragment formation, coupling, and macrocyclization. Together with efficient
05-08 02:09
Pyxis Oncology appoints Nelson Azoulay as Chief Business Officer. With over 15 years of experience in corporate strategy and biopharma transactions, Azoulay will lead corporate development and advance MICVO, the company's lead ADC targeting EDB+FN in solid tumors. MICVO is in Phase 1/2 trials for recurrent/metastatic head and neck cancer and has received FDA Fast Track Designation. Azoulay's expertise in ADCs and strategic transactions is expecte...
05-07 20:05
1.5月6日,瑞博生物宣布与勃林格殷格翰(BI)在代谢功能障碍相关脂肪性肝炎(MASH)领域的siRNA合作达成第三个关键里程碑 此次进展标志着双方合作研发进...
05-07 17:24
礼来Mounjaro已超越默沙东的癌症治疗药物Keytruda,成为全球最畅销的药物。
05-07 07:57
经济观察网 默沙东近期披露收购进展及最新业绩指引,已完成对Cidara Therapeutics收购,同时上调2026年营收及每股收益预期。 业务进展情况 近期...
05-06 01:06
华盛资讯5月5日讯,默沙东公布2026财年Q1业绩,公司Q1营收162.86亿美元,同比增长4.9%,归母净利润亏损42.40亿美元,由盈转亏。
05-05 06:07
派息除權日
|
每股總股息
| 派息日期 |
2026-03-16
|
0.85
|
2026-04-07
|
2025-12-15
|
0.85
|
2026-01-08
|
2025-09-15
|
0.81
|
2025-10-07
|
2025-06-16
|
0.81
|
2025-07-08
|
2025-03-17
|
0.81
|
2025-04-07
|
2024-12-16
|
0.81
|
2025-01-08
|
2024-09-16
|
0.77
|
2024-10-07
|
2024-06-17
|
0.77
|
2024-07-08
|
2024-03-14
|
0.77
|
2024-04-05
|
2023-12-14
|
0.77
|
2024-01-08
|
2023-09-14
|
0.73
|
2023-10-06
|
2023-06-14
|
0.73
|
2023-07-10
|
2023-03-14
|
0.73
|
2023-04-10
|
2022-12-14
|
0.73
|
2023-01-09
|
2022-09-14
|
0.69
|
2022-10-07
|
2022-06-14
|
0.69
|
2022-07-08
|
2022-03-14
|
0.69
|
2022-04-07
|
2021-12-14
|
0.69
|
2022-01-07
|
2021-09-14
|
0.65
|
2021-10-07
|
2021-06-14
|
0.65
|
2021-07-07
|
2021-03-12
|
0.65
|
2021-04-07
|
2020-12-14
|
0.65
|
2021-01-08
|
2020-09-14
|
0.61
|
2020-10-07
|
2020-06-12
|
0.61
|
2020-07-07
|
2020-03-13
|
0.61
|
2020-04-07
|
2019-12-13
|
0.61
|
2020-01-08
|
2019-09-13
|
0.55
|
2019-10-07
|
2019-06-14
|
0.55
|
2019-07-08
|
2019-03-14
|
0.55
|
2019-04-05
|
2018-12-14
|
0.55
|
2019-01-08
|
2018-09-14
|
0.48
|
2018-10-05
|
2018-06-14
|
0.48
|
2018-07-09
|
2018-03-14
|
0.48
|
2018-04-06
|
2017-12-14
|
0.48
|
2018-01-08
|
2017-09-14
|
0.47
|
2017-10-06
|
2017-06-13
|
0.47
|
2017-07-10
|
2017-03-13
|
0.47
|
2017-04-07
|
2016-12-13
|
0.47
|
2017-01-09
|
2016-09-13
|
0.46
|
2016-10-07
|
2016-06-13
|
0.46
|
2016-07-08
|
2016-03-11
|
0.46
|
2016-04-07
|
2015-12-11
|
0.46
|
2016-01-08
|
2015-09-11
|
0.45
|
2015-10-07
|
2015-06-11
|
0.45
|
2015-07-08
|
2015-03-12
|
0.45
|
2015-04-08
|
2014-12-11
|
0.45
|
2015-01-08
|
2014-09-11
|
0.44
|
2014-10-07
|
2014-06-12
|
0.44
|
2014-07-08
|
2014-03-13
|
0.44
|
2014-04-07
|
2013-12-12
|
0.44
|
2014-01-08
|
2013-09-12
|
0.43
|
2013-10-07
|
2013-06-13
|
0.43
|
2013-07-08
|
2013-03-13
|
0.43
|
2013-04-05
|
2012-12-13
|
0.43
|
2013-01-08
|
2012-09-13
|
0.42
|
2012-10-05
|
2012-06-13
|
0.42
|
2012-07-09
|
2012-03-13
|
0.42
|
2012-04-06
|
2011-12-13
|
0.42
|
2012-01-09
|
2011-09-13
|
0.38
|
2011-10-07
|
2011-06-13
|
0.38
|
2011-07-08
|
2011-03-11
|
0.38
|
2011-04-07
|
2010-12-13
|
0.38
|
2011-01-07
|
2010-09-13
|
0.38
|
2010-10-07
|
2010-06-11
|
0.38
|
2010-07-08
|
2010-03-11
|
0.38
|
2010-04-07
|
2009-12-11
|
0.38
|
2010-01-08
|
2009-09-02
|
0.38
|
2009-10-01
|
2009-06-04
|
0.38
|
2009-07-01
|
2009-03-04
|
0.38
|
2009-04-01
|
2008-12-03
|
0.38
|
2009-01-02
|
2008-09-03
|
0.38
|
2008-10-01
|
2008-06-04
|
0.38
|
2008-07-01
|
2008-03-05
|
0.38
|
2008-04-01
|
2007-12-05
|
0.38
|
2008-01-02
|
2007-09-05
|
0.38
|
2007-10-01
|
2007-06-06
|
0.38
|
2007-07-02
|
2007-03-07
|
0.38
|
2007-04-02
|
2006-12-06
|
0.38
|
2007-01-02
|
2006-08-30
|
0.38
|
2006-10-02
|
2006-05-31
|
0.38
|
2006-07-03
|
2006-03-08
|
0.38
|
2006-04-03
|
2005-11-30
|
0.38
|
2006-01-03
|
2005-08-31
|
0.38
|
2005-10-03
|
2005-06-01
|
0.38
|
2005-07-01
|
2005-03-02
|
0.38
|
2005-04-01
|
2004-12-01
|
0.38
|
2005-01-03
|
2004-09-01
|
0.38
|
2004-10-01
|
2004-06-02
|
0.37
|
2004-07-01
|
2004-03-03
|
0.37
|
2004-04-01
|
2003-12-03
|
0.37
|
2004-01-02
|
2003-09-03
|
0.37
|
2003-10-01
|
2003-06-04
|
0.36
|
2003-07-01
|
2003-03-05
|
0.36
|
2003-04-01
|
2002-12-04
|
0.36
|
2003-01-02
|
2002-09-04
|
0.36
|
2002-10-01
|
2002-06-05
|
0.35
|
2002-07-01
|
2002-03-06
|
0.35
|
2002-04-01
|
2001-12-05
|
0.35
|
2002-01-02
|
2001-08-30
|
0.35
|
2001-10-01
|
2001-05-31
|
0.34
|
2001-07-02
|
2001-03-07
|
0.34
|
2001-04-02
|
2000-12-06
|
0.34
|
2001-01-02
|
2000-08-30
|
0.34
|
2000-10-02
|
2000-05-31
|
0.29
|
2000-07-03
|
2000-03-01
|
0.29
|
2000-04-03
|
1999-12-01
|
0.29
|
2000-01-03
|
1999-09-01
|
0.29
|
1999-10-01
|
1999-06-02
|
0.27
|
1999-07-01
|
1999-03-03
|
0.27
|
1999-04-01
|
1998-12-02
|
0.54
|
1999-01-04
|
1998-09-02
|
0.54
|
1998-10-01
|
1998-06-03
|
0.45
|
1998-07-01
|
1998-03-04
|
0.45
|
1998-04-01
|
1997-12-03
|
0.45
|
1998-01-02
|
1997-09-03
|
0.45
|
1997-10-01
|
1997-06-05
|
0.42
|
1997-07-01
|
1997-03-05
|
0.42
|
1997-04-01
|
1996-12-05
|
0.40
|
1997-01-02
|
1996-09-04
|
0.40
|
1996-10-01
|
1996-06-06
|
0.34
|
1996-07-01
|
1996-03-06
|
0.34
|
1996-04-01
|
1995-12-06
|
0.34
|
1996-01-02
|
1995-09-05
|
0.34
|
1995-10-02
|
1995-06-02
|
0.30
|
1995-07-03
|
1995-03-03
|
0.30
|
1995-04-03
|
1994-12-02
|
0.30
|
1995-01-02
|
1994-09-02
|
0.30
|
1994-10-01
|
1994-06-02
|
0.28
|
1994-07-01
|
1994-03-02
|
0.28
|
1994-04-01
|
1993-12-02
|
0.28
|
1994-01-03
|
1993-09-02
|
0.28
|
1993-10-01
|
1993-06-02
|
0.25
|
1993-07-01
|
1993-03-02
|
0.25
|
1993-04-01
|
1992-12-02
|
0.25
|
1993-01-04
|
1992-08-31
|
0.25
|
1992-10-01
|
1992-06-02
|
0.23
|
1992-07-01
|
1992-03-02
|
0.69
|
1992-04-01
|
1991-12-02
|
0.63
|
1992-01-02
|
1991-08-30
|
0.63
|
1991-10-01
|
1991-06-03
|
0.56
|
1991-07-01
|
1991-03-04
|
0.56
|
1991-04-01
|
1990-12-03
|
0.56
|
1991-01-02
|
1990-08-28
|
0.56
|
1990-10-01
|
1990-05-29
|
0.45
|
1990-07-02
|
1990-03-05
|
0.45
|
1990-04-02
|
1989-12-04
|
0.45
|
1990-01-02
|
1989-08-29
|
0.45
|
1989-10-02
|
1989-05-30
|
0.41
|
1989-07-05
|
1989-03-02
|
0.41
|
1989-04-03
|
1988-11-29
|
0.37
|
1989-01-03
|
1988-08-29
|
0.37
|
1988-10-03
|
1988-06-03
|
0.32
|
1988-07-05
|
1988-02-29
|
0.96
|
1988-04-04
|
1987-12-01
|
0.80
|
1988-01-04
|
1987-08-28
|
0.80
|
1987-10-01
|
1987-06-02
|
0.55
|
1987-07-01
|
1987-03-02
|
0.55
|
1987-04-01
|
1986-12-02
|
0.55
|
1987-01-02
|
1986-09-02
|
0.55
|
1986-10-01
|
1986-06-03
|
0.45
|
1986-07-01
|
1986-02-27
|
0.90
|
1986-04-01
|
1985-12-03
|
0.90
|
1986-01-02
|
1985-08-30
|
0.80
|
1985-10-01
|
1985-06-03
|
0.80
|
1985-07-01
|
1985-02-28
|
0.80
|
1985-04-01
|
1984-12-03
|
0.80
|
1985-01-02
|
1984-08-31
|
0.75
|
1984-10-01
|
1984-05-29
|
0.75
|
1984-07-02
|
1984-03-01
|
0.75
|
1984-04-02
|
1983-11-29
|
0.75
|
1984-01-02
|
1983-08-29
|
0.70
|
1983-09-30
|
1983-05-31
|
0.70
|
1983-06-30
|
1983-02-28
|
0.70
|
1983-04-01
|
1982-11-30
|
0.70
|
1983-01-03
|
1982-08-30
|
0.70
|
1982-10-01
|
1982-06-01
|
0.70
|
1982-07-01
|
1982-03-01
|
0.70
|
1982-04-01
|
1981-12-01
|
0.70
|
1982-01-04
|
1981-08-31
|
0.65
|
1981-10-01
|
1981-06-01
|
0.65
|
1981-07-01
|
1981-03-02
|
0.65
|
1981-04-01
|
1980-12-02
|
0.65
|
1981-01-02
|
1980-08-29
|
0.57
|
1980-10-01
|
1980-06-02
|
0.57
|
1980-07-01
|
1980-02-27
|
0.57
|
1980-03-31
|
1979-12-02
|
0.57
|
1980-01-01
|
1979-08-30
|
0.47
|
1979-09-30
|
1979-05-24
|
0.47
|
1979-07-01
|
1979-02-28
|
0.47
|
1979-04-01
|
1978-12-03
|
0.47
|
1979-01-01
|
1978-08-27
|
0.43
|
1978-10-01
|
1978-05-25
|
0.43
|
1978-06-30
|
1978-03-01
|
0.43
|
1978-03-31
|
1977-11-27
|
0.43
|
1978-01-01
|
1977-08-28
|
0.38
|
1977-09-30
|
1977-05-30
|
0.38
|
1977-06-30
|
1977-02-28
|
0.38
|
1977-03-31
|
